These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 36293076)

  • 21. Osteoporosis and Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD): Back to Basics.
    Pazianas M; Miller PD
    Am J Kidney Dis; 2021 Oct; 78(4):582-589. PubMed ID: 33774081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The CKD-MBD Syndrome: Hysteresis in PTH Involvement and PTH Administration for Its Management.
    Pazianas M; Miller PD
    J Bone Miner Res; 2020 Dec; 35(12):2313-2317. PubMed ID: 32780482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin D, vitamin D receptor and the importance of its activation in patients with chronic kidney disease.
    Bover J; Egido J; Fernández-Giráldez E; Praga M; Solozábal-Campos C; Torregrosa JV; Martínez-Castelao A
    Nefrologia; 2015; 35(1):28-41. PubMed ID: 25611831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis and management of mineral and bone disorders in infants with CKD: clinical practice points from the ESPN CKD-MBD and Dialysis working groups and the Pediatric Renal Nutrition Taskforce.
    Bacchetta J; Schmitt CP; Bakkaloglu SA; Cleghorn S; Leifheit-Nestler M; Prytula A; Ranchin B; Schön A; Stabouli S; Van de Walle J; Vidal E; Haffner D; Shroff R
    Pediatr Nephrol; 2023 Sep; 38(9):3163-3181. PubMed ID: 36786859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survey of attitudes of physicians toward the current evaluation and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).
    Souqiyyeh MZ; Shaheen FA
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):93-101. PubMed ID: 20061700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vitamin D and Chronic Kidney Disease Association with Mineral and Bone Disorder: An Appraisal of Tangled Guidelines.
    Bover J; Massó E; Gifre L; Alfieri C; Soler-Majoral J; Fusaro M; Calabia J; Rodríguez-Pena R; Rodríguez-Chitiva N; López-Báez V; Sánchez-Baya M; da Silva I; Aguilar A; Bustos MC; Rodrigues N; Chávez-Iñiguez JS; Romero-González G; Valdivielso JM; Molina P; Górriz JL
    Nutrients; 2023 Mar; 15(7):. PubMed ID: 37049415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanistic insights into CKD-MBD-related vascular calcification and its clinical implications.
    Kaur R; Singh R
    Life Sci; 2022 Dec; 311(Pt B):121148. PubMed ID: 36336124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of Chronic Kidney Disease (CKD)-Mineral and Bone Disorder (MBD) in the Pathogenesis of Cardiovascular Disease in CKD.
    Yamada S; Nakano T
    J Atheroscler Thromb; 2023 Aug; 30(8):835-850. PubMed ID: 37258233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what's changed and why it matters.
    Ketteler M; Block GA; Evenepoel P; Fukagawa M; Herzog CA; McCann L; Moe SM; Shroff R; Tonelli MA; Toussaint ND; Vervloet MG; Leonard MB
    Kidney Int; 2017 Jul; 92(1):26-36. PubMed ID: 28646995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fractures in patients with CKD-diagnosis, treatment, and prevention: a review by members of the European Calcified Tissue Society and the European Renal Association of Nephrology Dialysis and Transplantation.
    Pimentel A; Ureña-Torres P; Zillikens MC; Bover J; Cohen-Solal M
    Kidney Int; 2017 Dec; 92(6):1343-1355. PubMed ID: 28964571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD).
    Ruospo M; Palmer SC; Natale P; Craig JC; Vecchio M; Elder GJ; Strippoli GF
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD006023. PubMed ID: 30132304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vitamin D and Secondary Hyperparathyroidism in Chronic Kidney Disease: A Critical Appraisal of the Past, Present, and the Future.
    Brandenburg V; Ketteler M
    Nutrients; 2022 Jul; 14(15):. PubMed ID: 35893866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of secondary hyperparathyroidism in non-dialysis CKD: an appraisal 2022s.
    Ketteler M; Bover J; Mazzaferro S
    Nephrol Dial Transplant; 2023 May; 38(6):1397-1404. PubMed ID: 35977397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Research on kidney and mineral metabolism in Japan: past, present, and future.
    Mizobuchi M; Ogata H; Koiwa F; Kinugasa E; Akizawa T
    Clin Exp Nephrol; 2017 Mar; 21(Suppl 1):4-8. PubMed ID: 28005175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integral pharmacological management of bone mineral disorders in chronic kidney disease (part II): from treatment of phosphate imbalance to control of PTH and prevention of progression of cardiovascular calcification.
    Bover J; Ureña-Torres P; Lloret MJ; Ruiz C; DaSilva I; Diaz-Encarnacion MM; Mercado C; Mateu S; Fernández E; Ballarin J
    Expert Opin Pharmacother; 2016 Jul; 17(10):1363-73. PubMed ID: 27156578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Chronic kidney disease - Mineral bone disorders: Physiopathology and guidelines].
    Lavainne F; Guillot P; Figueres L
    Rev Med Interne; 2022 Apr; 43(4):225-232. PubMed ID: 35227526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recommendations of the Spanish Society of Nephrology for the management of mineral and bone metabolism disorders in patients with chronic kidney disease: 2021 (SEN-MM).
    Torregrosa JV; Bover J; Rodríguez Portillo M; González Parra E; Dolores Arenas M; Caravaca F; González Casaus ML; Martín-Malo A; Navarro-González JF; Lorenzo V; Molina P; Rodríguez M; Cannata Andia J
    Nefrologia (Engl Ed); 2023 Jun; 43 Suppl 1():1-36. PubMed ID: 37202281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological Management of Secondary Hyperparathyroidism in Patients with Chronic Kidney Disease.
    Salam SN; Khwaja A; Wilkie ME
    Drugs; 2016 May; 76(8):841-52. PubMed ID: 27142279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bisphophonates in CKD patients with low bone mineral density.
    Liu WC; Yen JF; Lang CL; Yan MT; Lu KC
    ScientificWorldJournal; 2013; 2013():837573. PubMed ID: 24501586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.